MaxCyte (MXCT) Earnings Date, Estimates & Call Transcripts $2.65 +0.05 (+1.92%) Closing price 04:00 PM EasternExtended Trading$2.66 +0.00 (+0.19%) As of 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MaxCyte Earnings Summary Upcoming Q4 Earnings DateMay. 7Before Market OpensEstimatedConsensus EPS (Nov. 6) -$0.13 Actual EPS (Nov. 6) -$0.11 Beat By $0.02 Actual Revenue (Nov. 6) $8.16MMaxCyte issued Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.11, which beat analysts' consensus estimates of -$0.13 by $0.02. Quarterly revenue was reported to be $8.16 million, above analyst estimates of $7.50 million. With a trailing EPS of -$0.39, MaxCyte's earnings are expected to grow next year, from ($0.42) to ($0.41) per share. Q3 2024 Earnings ResourcesQ3 2024 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)MXCT Upcoming EarningsMaxCyte's Q1 2025 earnings is scheduled for Wednesday, May 7, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get MaxCyte Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MaxCyte and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMXCT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MXCT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads MaxCyte Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.10-$0.10-$0.10Q2 20251-$0.09-$0.09-$0.09Q3 20251-$0.08-$0.08-$0.08Q4 20251-$0.07-$0.07-$0.07FY 20254-$0.34-$0.34-$0.34Q1 20261-$0.09-$0.09-$0.09Q2 20261-$0.09-$0.09-$0.09Q3 20261-$0.07-$0.07-$0.07Q4 20261-$0.06-$0.06-$0.06FY 20264($0.31)($0.31)($0.31) Remove Ads MaxCyte Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/7/2025(Estimated)-------11/6/2024Q3 2024-$0.13-$0.11+$0.02-$0.11$7.50M$8.16M8/6/2024Q2 2024-$0.14-$0.09+$0.05-$0.09$8.20M$10.43M5/7/2024Q1 2024-$0.14-$0.09+$0.05-$0.09$7.75M$11.34M3/12/2024Q4 2023-$0.10-$0.05+$0.05-$0.05$15.60M$15.67M11/8/2023Q3 2023-$0.10-$0.11 -$0.01-$0.11$7.90M$8.01M8/9/2023Q2 2023-$0.10-$0.10--$0.10$11.00M$9.04M5/10/2023Q1 2023-$0.11-$0.11--$0.11$8.75M$8.58M MaxCyte Earnings - Frequently Asked Questions When is MaxCyte's earnings date? MaxCyte has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 7th, 2025 based off last year's report dates. Learn more on MXCT's earnings history. What guidance has MaxCyte issued on next quarter's earnings? MaxCyte updated its FY 2025 earnings guidance on Wednesday, March, 12th. The company issued revenue guidance of $35.1 million-$37.4 million, compared to the consensus revenue estimate of $41.4 million. Did MaxCyte beat their earnings estimates last quarter? In the previous quarter, MaxCyte (NASDAQ:MXCT) reported ($0.11) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.13) by $0.02. Learn more on analysts' earnings estimate vs. MXCT's actual earnings. How can I listen to MaxCyte's earnings conference call? The conference call for MaxCyte's latest earnings report can be listened to online. Listen to Conference Call How can I read MaxCyte's conference call transcript? The conference call transcript for MaxCyte's latest earnings report can be read online. Read Transcript How much revenue does MaxCyte generate each year? MaxCyte (NASDAQ:MXCT) has a recorded annual revenue of $38.63 million. How much profit does MaxCyte generate each year? MaxCyte (NASDAQ:MXCT) has a recorded net income of -$37.92 million. MXCT has generated -$0.39 earnings per share over the last four quarters. What is MaxCyte's EPS forecast for next year? MaxCyte's earnings are expected to grow from ($0.42) per share to ($0.41) per share in the next year. More Earnings Resources from MarketBeat Related Companies TASK Earnings Results SEZL Earnings Results OLO Earnings Results PRSU Earnings Results PSFE Earnings Results FVRR Earnings Results RDWR Earnings Results CTOS Earnings Results IIIV Earnings Results YEXT Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NASDAQ:MXCT) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MaxCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MXCT Stock Free MXCT Stock Alerts